<i>In Vitro</i> Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016Meredith Hackel, Daniel F. Sahm, Yoshinori Yamano et al.|Antimicrobial Agents and Chemotherapy|2017Cited by 234
Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosaKrystyna M. Kazmierczak, Patricia A. Bradford, Robert E. McLaughlin et al.|Antimicrobial Agents and Chemotherapy|2015Cited by 221
<i>In Vitro</i> Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study)Meredith Hackel, Daniel F. Sahm, Yoshinori Yamano et al.|Antimicrobial Agents and Chemotherapy|2017Cited by 196
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)Krystyna M. Kazmierczak, Daniel F. Sahm, Yoshinori Yamano et al.|International Journal of Antimicrobial Agents|2018Cited by 191
<i>In Vitro</i> Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015James A. Karlowsky, Patricia A. Bradford, Krystyna M. Kazmierczak et al.|Antimicrobial Agents and Chemotherapy|2017Cited by 190